iBio, Inc.

iBio, Inc. financial statements

iBio, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2026

RevenueUSD 100K10-K
Net income−USD 33.04M10-K
Cash and equivalentsUSD 56.4M10-Q
Total debtUSD 2.2MEODHD

iBio, Inc. financials on 6ix · iBio, Inc. on 6ix